BackNovoCure Overview

NovoCure Other Current Liabilities

NovoCure's other current liabilities is $90M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$89.98M
4.43% YoYΔ $3.81M vs prior year quarter

Peer trimmed avg / median

Loading

NovoCure Other Current Liabilities History

Loading

NovoCure vs. peers: Other Current Liabilities Comparison

Loading

NovoCure Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NovoCure (NVCR) FAQ

As of the most recent data (June 2026), NVCR shows a other current liabilities of $90M. That compares with $86M in the prior-year period — up 4.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVCR's other current liabilities is now $90M (was $86M) — a 4.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NovoCure is outperforming or lagging.

Tracking NVCR's other current liabilities over time shows whether NovoCure is scaling, shrinking, or reshaping that part of the business. The current reading is $90M That compares with $86M in the prior-year period — up 4.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has NovoCure's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $90M) with ownership activity and broader fundamentals.

NovoCure's other current liabilities is $90M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.